Starling Oncology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $65.7M
Liabilities Breakdown FY2020
Total Liabilities: $37.6M
Asset Breakdown
Total Assets: $65.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $900.0K | 1.4% |
| Accounts Receivable | $17.1M | 26.1% |
| Inventory | $4.4M | 6.6% |
| Property, Plant & Equipment | $2.1M | 3.2% |
| Goodwill | $14.2M | 21.7% |
| Intangible Assets | $19.5M | 29.7% |
| Other Assets | $7.4M | 11.3% |
Liabilities Breakdown
Total Liabilities: $37.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.6M | 33.6% |
| Long-Term Debt | $6.6M | 17.5% |
| Other Liabilities | $18.4M | 48.9% |